Celestica (NYSE:CLS) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.54 by 3.7 percent. This is a 27.27 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $2.04 billion which beat the analyst consensus estimate of $1.97 billion by 3.71 percent. This is a 35.12 percent increase over sales of $1.51 billion the same period last year.
Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock
Credit Suisse has initiated coverage on Johnson & Johnson (NYSE:JNJ) with a Neutral rating and a price target of $170. The…
